100 filings
Page 2 of 5
8-K
6n6asepnq i4627xd
11 Aug 22
Eledon Pharmaceuticals Reports Second Quarter 2022 Operating and Financial Results
4:06pm
8-K
gald2qvxl 6ty
22 Jun 22
Submission of Matters to a Vote of Security Holders
6:13pm
8-K
vaxf4bbydvdda
31 May 22
Eledon Announces Positive Topline Results from Phase 2a Trial of Tegoprubart
6:38am
8-K
0us51 0xh
12 May 22
Eledon Pharmaceuticals Reports First Quarter 2022 Operating and Financial Results
12:00am
8-K
ruyb64tk64e87 ad3
24 Mar 22
Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Operating and Financial Results
4:07pm
8-K
24b2z
13 Jan 22
Unregistered Sales of Equity Securities
4:00pm
8-K
xhtdiz6wfhgffw
12 Nov 21
Eledon Pharmaceuticals Reports Third Quarter 2021 Operating and Financial Results
6:32am
8-K
pcolmy927q8jl1nkd 2b
12 Aug 21
Eledon Pharmaceuticals Reports Second Quarter 2021 Operating and Financial Results
4:00pm
8-K
e32cj6pp3dkc1viqs0zb
2 Aug 21
Departure of Directors or Certain Officers
9:00am
8-K
ft50965
2 Jul 21
Departure of Directors or Certain Officers
8:30am
8-K
r7fnklxckfa23pc
16 Jun 21
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
a2arou
13 May 21
Eledon Pharmaceuticals Reports First Quarter 2021 Operating and Financial Results
4:22pm
8-K
0zcq0wgxp8rwbi5
27 Apr 21
Eledon Pharmaceuticals Announces Update on Development Strategy for AT-1501 in Renal Transplantation
12:00am
8-K
5xz osh4z
15 Mar 21
Departure of Directors or Certain Officers
2:00pm
8-K
brqfvygc
7 Jan 21
Unregistered Sales of Equity Securities
8:00am
8-K
5onuvkb91xm4 eywanm4
5 Jan 21
Novus Therapeutics Announces Name Change to Eledon Pharmaceuticals; Provides Corporate Update and Outlook
4:10pm
8-K
jnzggaus8a1tp5jpk5k
22 Dec 20
Submission of Matters to a Vote of Security Holders
8:16am
8-K
hghfz 0l5ktejlu
10 Dec 20
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
zwz84
20 Nov 20
Amendments to Articles of Incorporation or Bylaws
4:18pm
8-K/A
tz0s7
20 Nov 20
Financial Statements and Exhibits
8:32am